Showing 16,381 - 16,400 results of 103,943 for search '(( 5 ((mean decrease) OR (a decrease)) ) OR ( e ((nn decrease) OR (point decrease)) ))', query time: 1.73s Refine Results
  1. 16381
  2. 16382
  3. 16383
  4. 16384
  5. 16385

    Age at treatment initiation–cross sex hormones. by Lucy Thompson (3705940)

    Published 2023
    “…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
  6. 16386

    Study characteristics. by Lucy Thompson (3705940)

    Published 2023
    “…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
  7. 16387

    Age at treatment initiation–puberty suppression. by Lucy Thompson (3705940)

    Published 2023
    “…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
  8. 16388

    Search terms. by Lucy Thompson (3705940)

    Published 2023
    “…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
  9. 16389

    PRISMA diagram. by Lucy Thompson (3705940)

    Published 2023
    “…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
  10. 16390

    PRISMA 2020 checklist. by Lucy Thompson (3705940)

    Published 2023
    “…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
  11. 16391
  12. 16392
  13. 16393

    Data_Sheet_1_Blood Purification in Severe and Critical COVID-19 Patients: A Case Series of 5 Patients.docx by Hongjun Chen (132548)

    Published 2021
    “…</p><p>Results: Among the 5 patients, 4 were males ranging from 35 to 80 year old (Mean age = 63 ± 17.87). …”
  14. 16394
  15. 16395
  16. 16396

    Identification of Differentially Expressed Genes in the Pheromone Glands of Mated and Virgin <i>Bombyx mori</i> by Digital Gene Expression Profiling by Songdou Zhang (182871)

    Published 2014
    “…RNAi-mediated knockdown of putative JH receptor gene, <i>Methoprene tolerant 1</i> (<i>Met1</i>), in female pupa resulted in a significant decrease in sex pheromone production in mature females, suggesting the importance of JH in sex pheromone synthesis.…”
  17. 16397

    Short-delay 5CSRTT testing. by Melvin Maroon (18563487)

    Published 2024
    “…<p>A) There was a decrease in accuracy in offspring of poly I:C injected rats at the shortest delay of 0.5 s, regardless of genotype. …”
  18. 16398
  19. 16399
  20. 16400

    Outline of study participants. by Shahrzad Daei (20565172)

    Published 2025
    “…</p><p>Results</p><p>This study was implemented on 2,688 men and 3,260 women, respectively with the mean (SD) age of 41.5(14.1) and 39.3(13.02) years. …”